Prolia Linked to Higher Hypocalcemia Risk Among Female Dialysis Patients: Study
Researchers warn that severe hypocalcemia can increase the risk of bone fractures, hospitalization and death for dialysis patients.
Researchers warn that severe hypocalcemia can increase the risk of bone fractures, hospitalization and death for dialysis patients.
The FDA began investigating a link between side effects of Prolia and hypocalcemia in November 2022, following adverse reports from dialysis patients.
California judges determined Truvada lawsuits, Atripla lawsuits, Stribild lawsits, Viread lawsuits and Complera lawsuits can be pursued by users who developed kidney damage, bone fractures and other side effects from the HIV drugs.
Gilead claims it had no duty to develop safer TAF-based HIV drugs to replace its older TDF-based medications, including Truvada, Viread, Stribild and others, which have been linked to bone fractures, kidney injuries and other side effects.
Properly identifying patients at higher risk of transmission increases the benefits of prescribing certain HIV drugs as prophylactics, researchers determined.
The findings come as manufacturers of Nexium, Prilosec and similar heartburn drugs face a growing number of lawsuits over kidney damage
The study comes amid increasing concerns over lithium exposure, which has been linked not only to kidney injury, but birth defects as well.
Gilead failed adequately to warn users that its TDF-based HIV drugs could lead to bone demineralization, kidney disease and kidney damage, plaintiffs say.
Plaintiffs say they suffered bone demineralization, resulting in bone density loss and permanent injuries due to Gilead's marketing of a less safe formulation of the drugs in order to make more money.
More than 13,000 Nexium lawsuits, Prilosec lawsuits, Protonix lawsuits and other complaints involving kidney side effects from proton pump inhibitor (PPI) heartburn drugs are pending throughout the federal court system.